<DOC>
	<DOCNO>NCT00033878</DOCNO>
	<brief_summary>The purpose Phase 1 study : 1. determine maximum tolerate dose capsule contain 500mg freeze dry noni fruit extract , 2. define toxicity associate ingestion noni , 3. collect preliminary information efficacy noni respect anti-tumor symptom control property help select specific patient subsequent Phase 2 study , 4. identify chemical constituent extract use characterize bioavailability pharmacokinetics noni food supplement .</brief_summary>
	<brief_title>Study Noni Cancer Patients</brief_title>
	<detailed_description>This Phase I study noni cancer patient represent first step systematic study Complementary Alternative Medicine ( CAM ) practice draw Asian Pacific Island cultural tradition heal control cancer relate symptom . Noni , extract Morinda citifolia Indian mulberry plant , include traditional pharmacopoeia Native Hawaiians , Pacific Islanders Asian population , use treat various disease hundred year . It commonly take cancer patient base purported usefulness disease although little scientific evidence either support refute claim . A large marketing enterprise least eleven different supplier support food supplement 's popularity . The broad long range objective study initiate define usefulness noni extract cancer patient . The hypothesis test noni specify dose provide cancer patient sufficient benefit toxicity profile useful therapeutic . Specific aim study : 1 . Determine maximum tolerate dose capsule contain 500mg freeze-dried noni fruit extract . 2 . Define toxicity associate ingestion noni . 3 . Collect preliminary information efficacy noni respect anti-tumor symptom control property help select specific patient subsequent Phase II study . 4 . Identify chemical constituent extract use characterize bioavailability pharmacokinetics noni food supplement .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Patients must : Have pathologically cytologically verified diagnosis cancer evidence disease standard treatment available ; Be ambulatory , capable self care , 50 % waking hour ; Have complete cancer treatment least four week previously ; Have medication consider physician essential health ( e.g . lipid lowering , antidiabetic , antihypertensive ) consistent dose least four week prior start noni ; Agree take CAM treatment take noni agree keep diary , record medication take daily , include non prescription product record time noni take .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Advanced Cancer</keyword>
</DOC>